These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 32197468)

  • 1. An Integrated Meta-Analysis of Secretome and Proteome Identify Potential Biomarkers of Pancreatic Ductal Adenocarcinoma.
    de Oliveira G; Freire PP; Cury SS; de Moraes D; Oliveira JS; Dal-Pai-Silva M; Reis PP; Carvalho RF
    Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32197468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a metastasis-related Gene Signature for predicting the Overall Survival in patients with Pancreatic Ductal Adenocarcinoma.
    Wu M; Li X; Liu R; Yuan H; Liu W; Liu Z
    J Cancer; 2020; 11(21):6299-6318. PubMed ID: 33033514
    [No Abstract]   [Full Text] [Related]  

  • 3. Secretome protein signature of human pancreatic cancer stem-like cells.
    Brandi J; Dalla Pozza E; Dando I; Biondani G; Robotti E; Jenkins R; Elliott V; Park K; Marengo E; Costello E; Scarpa A; Palmieri M; Cecconi D
    J Proteomics; 2016 Mar; 136():1-12. PubMed ID: 26850699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated transcriptome meta-analysis of pancreatic ductal adenocarcinoma and matched adjacent pancreatic tissues.
    Atay S
    PeerJ; 2020; 8():e10141. PubMed ID: 33194391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and Validation of Three PDAC Subtypes and Individualized GSVA Immune Pathway-Related Prognostic Risk Score Formula in Pancreatic Ductal Adenocarcinoma Patients.
    Zhang D; Wang M; Peng L; Yang X; Li K; Yin H; Xia C; Cui F; Huang H; Jin Z
    J Oncol; 2021; 2021():4986227. PubMed ID: 34987579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma.
    Tang R; Liu X; Liang C; Hua J; Xu J; Wang W; Meng Q; Liu J; Zhang B; Yu X; Shi S
    Front Immunol; 2021; 12():648917. PubMed ID: 33777046
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognostic Implications of an Autophagy-related Gene Signature in Pancreatic Ductal Adenocarcinoma.
    Liu WS; Feng YX; Li SN; Shao YJ; Wang K
    Am J Clin Oncol; 2022 Mar; 45(3):95-104. PubMed ID: 35195559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying
    Ding J; Liu Y; Lai Y
    PeerJ; 2020; 8():e10419. PubMed ID: 33282565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and Validation of a Diagnostic and Prognostic Multi-Gene Biomarker Panel for Pancreatic Ductal Adenocarcinoma.
    Klett H; Fuellgraf H; Levit-Zerdoun E; Hussung S; Kowar S; Küsters S; Bronsert P; Werner M; Wittel U; Fritsch R; Busch H; Boerries M
    Front Genet; 2018; 9():108. PubMed ID: 29675033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identify potential clinical significance of long noncoding RNA forkhead box P4 antisense RNA 1 in patients with early stage pancreatic ductal adenocarcinoma.
    Liu XG; Xu H; Chen M; Tan XY; Chen XF; Yang YG; Lin MZ; Liu GH; Liang XL; Qian YB; Yuan GJ; Chen MQ; Li WT; Miao HL; Li MY; Liao XW; Dai W; Chen NP
    Cancer Med; 2020 Mar; 9(6):2062-2076. PubMed ID: 31991068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of transcriptome data identifies a novel 5-gene pancreatic adenocarcinoma classifier.
    Bhasin MK; Ndebele K; Bucur O; Yee EU; Otu HH; Plati J; Bullock A; Gu X; Castan E; Zhang P; Najarian R; Muraru MS; Miksad R; Khosravi-Far R; Libermann TA
    Oncotarget; 2016 Apr; 7(17):23263-81. PubMed ID: 26993610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five key lncRNAs considered as prognostic targets for predicting pancreatic ductal adenocarcinoma.
    Song J; Xu Q; Zhang H; Yin X; Zhu C; Zhao K; Zhu J
    J Cell Biochem; 2018 Jun; 119(6):4559-4569. PubMed ID: 29239017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Inflammatory Response Related Gene Signature Associated with Survival Outcome and Gemcitabine Response in Patients with Pancreatic Ductal Adenocarcinoma.
    Xiao Z; Li J; Yu Q; Zhou T; Duan J; Yang Z; Liu C; Xu F
    Front Pharmacol; 2021; 12():778294. PubMed ID: 35002712
    [No Abstract]   [Full Text] [Related]  

  • 14. Co-expression analysis of pancreatic cancer proteome reveals biology and prognostic biomarkers.
    Mantini G; Vallés AM; Le Large TYS; Capula M; Funel N; Pham TV; Piersma SR; Kazemier G; Bijlsma MF; Giovannetti E; Jimenez CR
    Cell Oncol (Dordr); 2020 Dec; 43(6):1147-1159. PubMed ID: 32860207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of an unfolded protein response-related signature for predicting the prognosis of pancreatic ductal adenocarcinoma.
    Fang L; Chen S; Gong H; Xia S; Guan S; Quan N; Li Y; Zeng C; Chen Y; Du J; Liu S
    Front Oncol; 2022; 12():1060508. PubMed ID: 36727081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Immune-Related Signatures Related to CD4+ T Cell Infiltration With Gene Co-Expression Network in Pancreatic Adenocarcinoma.
    Tan Z; Lei Y; Zhang B; Shi S; Liu J; Yu X; Xu J; Liang C
    Front Oncol; 2021; 11():674897. PubMed ID: 34367961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel immunogenomic signature to predict prognosis and reveal immune infiltration characteristics in pancreatic ductal adenocarcinoma.
    Li A; Ye B; Lin F; Wang Y; Miao X; Jiang Y
    Precis Clin Med; 2022 Jun; 5(2):pbac010. PubMed ID: 35694712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-scale analysis to identify prognostic microRNA biomarkers in patients with early stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy.
    Liao X; Wang X; Huang K; Yang C; Yu T; Han C; Zhu G; Su H; Huang R; Peng T
    Cancer Manag Res; 2018; 10():2537-2551. PubMed ID: 30127641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SCNrank: spectral clustering for network-based ranking to reveal potential drug targets and its application in pancreatic ductal adenocarcinoma.
    Liu E; Zhang ZZ; Cheng X; Liu X; Cheng L
    BMC Med Genomics; 2020 Apr; 13(Suppl 5):50. PubMed ID: 32241274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined Expression of Plasma Thrombospondin-2 and CA19-9 for Diagnosis of Pancreatic Cancer and Distal Cholangiocarcinoma: A Proteome Approach.
    Le Large TYS; Meijer LL; Paleckyte R; Boyd LNC; Kok B; Wurdinger T; Schelfhorst T; Piersma SR; Pham TV; van Grieken NCT; Zonderhuis BM; Daams F; van Laarhoven HWM; Bijlsma MF; Jimenez CR; Giovannetti E; Kazemier G
    Oncologist; 2020 Apr; 25(4):e634-e643. PubMed ID: 31943574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.